Protease-sensitive regions in amyloid light chains: what a common pattern of fragmentation across organs suggests about aggregation

FEBS J. 2022 Jan;289(2):494-506. doi: 10.1111/febs.16182. Epub 2021 Sep 15.

Abstract

Light-chain (AL) amyloidosis is characterized by deposition of immunoglobulin light chains (LC) as fibrils in target organs. Alongside the full-length protein, abundant LC fragments are always present in AL deposits. Herein, by combining gel-based and mass spectrometry analyses, we identified and compared the fragmentation sites of amyloid LCs from multiple organs of an AL λ amyloidosis patient (AL-55). The positions pinpointed here in kidney and subcutaneous fat, alongside those previously detected in heart of the same patient, were aligned and mapped on the LC's dimeric and fibrillar states. All tissues contain fragmented LCs along with the full-length protein; the fragment pattern is coincident across organs, although microheterogeneity exists. Multiple cleavage positions were detected; some are shared, whereas some are organ-specific, likely due to a complex of proteases. Cleavage sites are concentrated in 'proteolysis-prone' regions, common to all tissues. Several proteolytic sites are not accessible on native dimers, while they are compatible with fibrils. Overall, data suggest that the heterogeneous ensemble of LC fragments originates in tissues and is consistent with digestion of preformed fibrils, or with the hypothesis that initial proteolytic cleavage of the constant domain triggers the amyloidogenic potential of LCs, followed by subsequent proteolytic degradation. This work provides a unique set of molecular data on proteolysis from ex vivo amyloid, which allows discussing hypotheses on role and timing of proteolytic events occurring along amyloid formation and accumulation in AL patients.

Keywords: amyloid fibrils; amyloidogenesis; immunoglobulin light chains; proteolysis; proteomics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid / genetics*
  • Amyloid / metabolism
  • Amyloid Neuropathies / genetics*
  • Amyloid Neuropathies / metabolism
  • Amyloid Neuropathies / pathology
  • Amyloidogenic Proteins / genetics*
  • Amyloidosis / genetics*
  • Amyloidosis / metabolism
  • Amyloidosis / pathology
  • Endopeptidases / genetics
  • Humans
  • Immunoglobulin Light Chains / genetics*
  • Immunoglobulin Light Chains / metabolism
  • Kinetics
  • Peptide Hydrolases / genetics
  • Protein Aggregation, Pathological / genetics
  • Protein Aggregation, Pathological / metabolism
  • Protein Aggregation, Pathological / pathology
  • Proteolysis
  • Thermodynamics

Substances

  • Amyloid
  • Amyloidogenic Proteins
  • Immunoglobulin Light Chains
  • Endopeptidases
  • Peptide Hydrolases